Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
- Status
- UNKNOWN
- Phase
- PHASE2
Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.
- Status
- COMPLETED
- Phase
- PHASE2
Gonadal Toxicity in Women With Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
124I-FIAU Imaging in EBV and KSHV Associated Cancers
- Status
- COMPLETED
- Phase
- NA
Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Early Chemotherapy Intensification in Interim-Positron Emission Tomography (PET) Positive Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
Proton Therapy for Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- NA
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Methionine PET/CT Studies In Patients With Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)
- Status
- UNKNOWN
- Phase
- PHASE2
HD16 for Early Stage Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)
- Status
- UNKNOWN
- Phase
- PHASE2